Texas Oncology - Fort Worth is a clinical research site located in Fort Worth, Texas, United States 76104.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Texas Oncology - Fort Worth has participated in 13 clinical trials with 5 currently active.
Therapeutic areas: Relapsed/Refractory Diffuse Large B-cell Lymphoma, Metastatic or Recurrent Squamous Cell Carcinoma of the Lung, Colorectal Cancer.
Sponsors: Karyopharm Therapeutics Inc, Oncolytics Biotech, HiberCell, Inc..
Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology - Fort Worth has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology - Fort Worth has 13 clinical trials on record, with 5 currently active. Their work covers Relapsed/Refractory Diffuse Large B-cell Lymphoma, Metastatic or Recurrent Squamous Cell Carcinoma of the Lung, Colorectal Cancer.
Texas Oncology - Fort Worth has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.